Cargando…
AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients
INTRODUCTION: The high incidence of actinic keratoses among both the elderly population and immunocompromised subjects and the considerable risk of progression from in situ to invasive neoplasms makes it essential to identify new prevention, treatment, and monitoring strategies. OBJECTIVE: The aim o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489998/ https://www.ncbi.nlm.nih.gov/pubmed/36160127 http://dx.doi.org/10.3389/fmed.2022.987696 |
_version_ | 1784792993588314112 |
---|---|
author | Veronese, Federica Seoni, Silvia Tarantino, Vanessa Buttafava, Matteo Airoldi, Chiara Meiburger, Kristen M. Zavattaro, Elisa Savoia, Paola |
author_facet | Veronese, Federica Seoni, Silvia Tarantino, Vanessa Buttafava, Matteo Airoldi, Chiara Meiburger, Kristen M. Zavattaro, Elisa Savoia, Paola |
author_sort | Veronese, Federica |
collection | PubMed |
description | INTRODUCTION: The high incidence of actinic keratoses among both the elderly population and immunocompromised subjects and the considerable risk of progression from in situ to invasive neoplasms makes it essential to identify new prevention, treatment, and monitoring strategies. OBJECTIVE: The aim of this study was to evaluate the efficacy on AKs of a topical product ((®)Rilastil AK Repair 100 +) containing high-protection sunscreens, a DNA Repair Complex with antioxidant and repairing action against UV-induced DNA damage, and nicotinamide, a water-soluble derivative of vitamin B3 that demonstrated several photoprotective effects both in vitro and in vivo. METHODS: The study enrolled 74 Caucasian patients, which included 42 immunocompetent and 32 immunosuppressed subjects. The efficacy of the treatment has been evaluated through the clinical index AKASI score and the non-invasive Near-Infrared Spectroscopy method. RESULTS: The AKASI score proved to be a valid tool to verify the efficacy of the product under study, highlighting an average percentage reduction at the end of treatment of 31.37% in immunocompetent patients and 22.76% in organ transplant recipients, in comparison to the initial values, with a statistically significant reduction also in the single time intervals (T0 vs. T1 and T1 vs. T2) in both groups. On the contrary, the Near-Infrared Spectroscopy (a non-invasive technique that evaluates hemoglobin relative concentration variations) did not find significant differences for O(2)Hb and HHb signals before and after the treatment, probably because the active ingredients of the product under study can repair the photo-induced cell damage, but do not significantly modify the vascularization of the treated areas. CONCLUSION: The results deriving from this study demonstrate the efficacy of the product under study, confirming the usefulness of the AKASI score in monitoring treated patients. Near-Infrared Spectroscopy could represent an interesting strategy for AK patients monitoring, even if further large-scale studies will be needed. |
format | Online Article Text |
id | pubmed-9489998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94899982022-09-22 AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients Veronese, Federica Seoni, Silvia Tarantino, Vanessa Buttafava, Matteo Airoldi, Chiara Meiburger, Kristen M. Zavattaro, Elisa Savoia, Paola Front Med (Lausanne) Medicine INTRODUCTION: The high incidence of actinic keratoses among both the elderly population and immunocompromised subjects and the considerable risk of progression from in situ to invasive neoplasms makes it essential to identify new prevention, treatment, and monitoring strategies. OBJECTIVE: The aim of this study was to evaluate the efficacy on AKs of a topical product ((®)Rilastil AK Repair 100 +) containing high-protection sunscreens, a DNA Repair Complex with antioxidant and repairing action against UV-induced DNA damage, and nicotinamide, a water-soluble derivative of vitamin B3 that demonstrated several photoprotective effects both in vitro and in vivo. METHODS: The study enrolled 74 Caucasian patients, which included 42 immunocompetent and 32 immunosuppressed subjects. The efficacy of the treatment has been evaluated through the clinical index AKASI score and the non-invasive Near-Infrared Spectroscopy method. RESULTS: The AKASI score proved to be a valid tool to verify the efficacy of the product under study, highlighting an average percentage reduction at the end of treatment of 31.37% in immunocompetent patients and 22.76% in organ transplant recipients, in comparison to the initial values, with a statistically significant reduction also in the single time intervals (T0 vs. T1 and T1 vs. T2) in both groups. On the contrary, the Near-Infrared Spectroscopy (a non-invasive technique that evaluates hemoglobin relative concentration variations) did not find significant differences for O(2)Hb and HHb signals before and after the treatment, probably because the active ingredients of the product under study can repair the photo-induced cell damage, but do not significantly modify the vascularization of the treated areas. CONCLUSION: The results deriving from this study demonstrate the efficacy of the product under study, confirming the usefulness of the AKASI score in monitoring treated patients. Near-Infrared Spectroscopy could represent an interesting strategy for AK patients monitoring, even if further large-scale studies will be needed. Frontiers Media S.A. 2022-09-07 /pmc/articles/PMC9489998/ /pubmed/36160127 http://dx.doi.org/10.3389/fmed.2022.987696 Text en Copyright © 2022 Veronese, Seoni, Tarantino, Buttafava, Airoldi, Meiburger, Zavattaro and Savoia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Veronese, Federica Seoni, Silvia Tarantino, Vanessa Buttafava, Matteo Airoldi, Chiara Meiburger, Kristen M. Zavattaro, Elisa Savoia, Paola AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title | AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title_full | AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title_fullStr | AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title_full_unstemmed | AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title_short | AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
title_sort | akasi and near-infrared spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489998/ https://www.ncbi.nlm.nih.gov/pubmed/36160127 http://dx.doi.org/10.3389/fmed.2022.987696 |
work_keys_str_mv | AT veronesefederica akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT seonisilvia akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT tarantinovanessa akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT buttafavamatteo akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT airoldichiara akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT meiburgerkristenm akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT zavattaroelisa akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients AT savoiapaola akasiandnearinfraredspectroscopyinthecombinedeffectivenessevaluationofanactinickeratosespreventiveproductinimmunocompetentandimmunocompromisedpatients |